Gene334
APLP2: amyloid beta precursor like protein 2
13 sourcesgene-search-2026-11-13-0.2.1
Cite this record
ConductScience Library. APLP2: amyloid beta precursor like protein 2. Genes, record 334. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/334
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q06481 | Amyloid beta precursor like protein 2 | 763 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents140
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260201011 A1 | 2026-07-16 | 922 | Q06481 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 414 | Q06481 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 5499 | Q06481 | Espacenet |
| US 20260125700 A1 | 2026-05-07 | 922 | Q06481 | Espacenet |
| US 20260125701 A1 | 2026-05-07 | 922 | Q06481 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 37323 | Q06481 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2219 | Q06481 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 2219 | Q06481 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 922 | Q06481 | Espacenet |
| US 12415844 B2 | 2025-09-16 | 922 | Q06481 | Espacenet |
NIH grants767
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | APLP2 papers | Newest fiscal year |
|---|---|---|---|
| T32CA009476 | Cancer Biology Training Program | 11 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 10 | 2025 |
| P30AG072975 | Rush Alzheimer's Disease Research Center | 2 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
| R01AG020670 | Knockin mouse models of Alzheimer's Disease | 2 | 2025 |
| ZIAAG000936 | Alzheimers Disease Project: Neuroimmune responses and therapeutics of alpha-synucleinopathies of the aging population | 2 | 2025 |
| ZIAHD001607 | Protein Trafficking In The Endosomal-Lysosomal System | 2 | 2025 |
| ZIAHG000215 | Human Biochemical Genetics | 2 | 2025 |
| I01BX005642 | Skeletal Muscular Swedish Mutant APP in Alzheimer's Disease Development | 1 | 2025 |
Source NIH's project files
Papers968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oxeiptosis-Associated Molecular Subtyping and Immune Microenvironment Heterogeneity in Osteoarthritis. | Biomedicines | 2026 | 42792820 | PubTator, text mining | PubMed |
| Trans-dimerization of Amyloid Precursor Protein Family Members Induces Pre- and Postsynaptic Differentiation through Distinct Signaling Pathways. | J Neurosci | 2026 | 42336662 | PubTator, text mining | PubMed |
| APLP2 as a molecular link between immune regulation and bone metabolism in hepatocellular carcinoma: evidence from scRNA-seq and functional validation. | Cancer Cell Int | 2026 | 42289676 | PubTator, text mining | PubMed |
| Family-Based GWAS of Cognitive Endophenotypes Reveals Genetic Architecture of Memory and Executive Function in Alzheimer's Disease. | Curr Issues Mol Biol | 2026 | 42193047 | PubTator, text mining | PubMed |
| Endothelial soluble APP/APLP2 promote heart repair through KIT-mediated angiogenesis. | Sci Adv | 2026 | 42172320 | PubTator, text mining | PubMed |
| Integrated single-cell and spatial mapping coupled with machine learning unveils core stemness landscapes and regulatory drivers in triple-negative breast cancer. | Discov Oncol | 2026 | 41870799 | PubTator, text mining | PubMed |
| β-amyloid and β-amyloid precursor protein synthesis and processing: effects of exercise and exercise-related injury. | Front Cell Neurosci | 2026 | 41737532 | PubTator, text mining | PubMed |
| Bridging cancer cell-intrinsic driver genes and -extrinsic cell-cell communication with Driver2Comm. | PLoS Comput Biol | 2026 | 41701761 | PubTator, text mining | PubMed |
| Recent advances in bispecific antibody-drug conjugates for breast cancer therapy. | Cancer Chemother Pharmacol | 2026 | 41579215 | PubTator, text mining | PubMed |
| A cytokine receptor-targeting chimera toolbox for expanding extracellular targeted protein degradation. | Proc Natl Acad Sci U S A | 2026 | 41564137 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/334
GET https://conductscience.org/api/genes/v1/334/patents?page=2